Direct Acting Antivirals Impact on Biochemical, Immunological and Hematological Responses in HCV Infected Patients

Direct Acting Anti-Viral Therapy, and Potential Increase in the Incidence of Hepato-Cellular Carcinoma in Cirrhotic Patients With Hepatitis C Virus

Effect of Direct Acting Anti-viral Agents on Insulin Resistance in Chronic HCV Patients

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Characterization of Drug –resistance Profiles to Directly Acting Agents in Hepatitis C virus Naive Patients

Effect of Treatment of Hepatitis C by Directly Acting Antivirals (DAA) on Chronic Hepatitis C, B Coinfected Patients

Impact of Hepatitis C virus Infection and direct-acting Oral Antiviral Drugs on glycaemic state in Type 2 Diabetic Patients

Effect of Direct Acting Anti-Hepatitis C Drugs on the Heart

Incidence of Acute Kidney Injury in HCV Infected Patients Receiving Direct-Acting Antivirals

Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs